| 000 | 01811 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250512113132.0 | ||
| 264 | 0 | _c19741216 | |
| 008 | 197412s 0 0 eng d | ||
| 022 | _a0027-8424 | ||
| 024 | 7 |
_a10.1073/pnas.71.8.2937 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSarji, K E | |
| 245 | 0 | 0 |
_aNature of von Willebrand factor: a new assay and a specific inhibitor. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cAug 1974 |
||
| 300 |
_a2937-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenosine Diphosphate _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibodies |
| 650 | 0 | 4 | _aAntigen-Antibody Reactions |
| 650 | 0 | 4 |
_aBiological Assay _xmethods |
| 650 | 0 | 4 |
_aBlood Coagulation Factors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aBlood Platelets _xmetabolism |
| 650 | 0 | 4 |
_aCollagen _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEpinephrine _xpharmacology |
| 650 | 0 | 4 |
_aFactor VIII _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFreezing |
| 650 | 0 | 4 | _aHot Temperature |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmune Sera |
| 650 | 0 | 4 | _aMacromolecular Substances |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeutralization Tests |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aRabbits _ximmunology |
| 650 | 0 | 4 |
_aRistocetin _xpharmacology |
| 650 | 0 | 4 |
_avon Willebrand Diseases _xblood |
| 700 | 1 | _aStratton, R D | |
| 700 | 1 | _aWagner, R H | |
| 700 | 1 | _aBrinkhous, K M | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 71 _gno. 8 _gp. 2937-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.71.8.2937 _zAvailable from publisher's website |
| 999 |
_c4551424 _d4551424 |
||